| COS Unique Id: |
107111 |
| Title: |
AIDS-Science Track Award for Research Transition (R03) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
September 7, 2008
September 7, 2009
|
| Deadline Note: |
Application receipt dates are September 7, 2007; September 7, 2008; and September 7, 2009.
This program will expire on September 8, 2009. |
| Upper Amount: |
$200,000 |
| Amount Note: |
This program will use the R03 grant mechanism.
Budgets for direct costs of up to $100,000 per year and a project
duration of up to two years may be requested for a maximum of $200,000
direct costs over a two-year project period. Commensurate Facilities
and Administrative (F&A) costs are allowed. |
| Eligibility: |
Applications may be submitted by domestic or
foreign, for-profit or nonprofit organizations and public or private
institutions, such as universities, colleges, hospitals, and
laboratories; units of state and local governments; eligible agencies
of the federal government; and faith-based or community-based
organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The National Institute on Drug Abuse (NIDA) seeks
to facilitate the entry of investigators to the area of drug abuse
research on HIV/AIDS, including both newly independent investigators
(independent of a mentor but without R01 funding) and early career
investigators who seek to add research on the intersection of drug
abuse and HIV/AIDS to their research programs (applicants may have an
existing R01 grant but not one combining drug abuse and HIV/AIDS
research). HIV/AIDS research is a major focus at NIDA, but it is often
difficult for new investigators to obtain independent funding to
generate preliminary data or for early career investigators doing drug
abuse or HIV/AIDS research to identify a source of funding that would
allow them to expand their research to study the intersection of drug
abuse and HIV/AIDS research.
To promote the entry of new
investigators into research on the natural history, epidemiology,
etiology and pathogenesis, prevention, and treatment of HIV/AIDS in
drug abusers, this AIDS-Science Track Award for Research Transition
(A-START) Funding Opportunity Announcement (FOA) (R03) will support
- pilot or feasibility studies,
- secondary analysis of existing data,
- small, self-contained research projects,
- development of research methodology, and
- development of new research technology.
It
is expected that investigators who are funded under A-START will use
their data to develop R01 grant applications on the intersection of
drug abuse and HIV/AIDS. |
| Contact Name: |
Christine Kidd |
| Contact Address: |
Grants Management Branch
National Institute on Drug Abuse/NIH/DHHS
6101 Executive Boulevard
Suite 270, MSC 8403 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-8403 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 443-6710 |
| Contact Fax: |
+1 (301) 594-6847 |
| Contact Email: |
ckidd@nida.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/pa-files/PA-07-349.html |
| Date Last Revised: |
March 26, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=107111 |
| Keywords: |
AIDS (Substance Abuse)
HIV
|
| Sponsor Reference No: |
PA-07-349 |
| Funding Type: |
Research
|
| COS Unique Id: |
113172 |
| Title: |
Pilot Grant Program |
| Sponsor: |
Limb Preservation Foundation
|
| Sponsor Type: |
Other Nonprofit |
| Deadline: |
May 15, 2008
|
| Upper Amount: |
$50,000 |
| Amount Note: |
Research grants will be made for research to take
place in the next 12 months beginning June 15, 2008. Under exceptional
circumstances, grants may be extended for longer than one year with the
approval of the LPF. Direct costs are not to exceed $40,000. It is the
policy of the LPF that indirect cost recovery (ICR) will be no more
than 20 percent. Total costs amount to a $50,000 maximum (direct plus
indirect). |
| Eligibility: |
Scientists and clinicians of nonprofit research,
medical service, and educational institutions are eligible to apply for
grants. Educational institution applicants must have faculty status or
a mentor with faculty status.
Particular emphasis will be
placed on support of independent junior investigators, postdoctoral,
and research fellows (M.D., DVM, or Ph.D. certified). |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The purpose of the LPF Research Grants Program is
to support exceptional research projects that will help lead to better
methods to save limbs in jeopardy. Grants being accepted in 2008 will
involve the diagnosis and treatment of adult/pediatric bone
malignancies. The purpose of this pilot grant will be to fund
innovative techniques which may attract additional sources of monies
for ongoing work.
Laboratory or clinical research will be
considered for funding. Pilot studies that will become eligible for
further funding through conventional support mechanisms will receive
priority. |
| Contact Name: |
Katie Mortimer, Director of Program Services |
| Contact Address: |
The Limb Preservation Foundation
1600 Broadway, Suite 2400 |
| Contact City: |
Denver |
| Contact State: |
Colorado |
| Contact Zip: |
80202 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (303) 217-0997 |
| Contact Email: |
katie@limbpreservation.org |
| URL for more information: |
http://www.limbpreservation.org/?page=2007ResearchGrantAnnouncement |
| Date Last Revised: |
March 28, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113172 |
| Keywords: |
Bone
Osteology or Osteopathy
|
| Funding Type: |
Research
|
| COS Unique Id: |
113194 |
| Title: |
Symptom Interactions in Cancer and Immune Disorders (R01) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 5, 2008
October 5, 2008
February 5, 2009
|
| Deadline Note: |
The opening date is May 5, 2008. AIDS-related
applications are due May 7, September 7, and January 7, annually. The
expiration date is May 8, 2011. |
| Amount Note: |
This FOA will utilize the R01 grant mechanism.
Awards issued under this FOA are contingent upon the availability of
funds and the submission of a sufficient number of meritorious
applications. Facilities and Administrative (F&A) costs requested
by consortium participants are not included in the direct cost
limitation.
This program does not require cost sharing. |
| Eligibility: |
Eligible applicants include institutions of higher
education; nonprofits, for-profits, and small businesses; state and
local governments; Indian/Native American tribal governments and
tribally designated organizations; regional organizations; non-domestic
organizations; eligible agencies of the federal government; and
faith-based or community-based organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
This funding opportunity announcement (FOA) issued
by the National Institute of Nursing Research (NINR), National Cancer
Institute (NCI), National Center on Complementary and Alternative
Medicine (NCCAM), National Institute on Aging (NIA), National
Institutes of Health (NIH), solicits grant applications from applicant
organizations that propose to
- identify and assess biological or biobehavioral interactions among two or more related and co-occurring symptoms;
- characterize mechanisms and pathways underlying the symptom interactions;
- elucidate the level of interaction necessary for categorization as a symptom cluster; or
-
design and test interventions targeted to interacting or clustered
symptoms that are hypothesized to lead to beneficial patient outcomes.
A
rationale for the choice of symptoms is needed, not just co-occurrence
of two or more symptoms. The symptoms must be associated with a target
disease or syndrome, or the treatment of this disease or syndrome.
Studies at any point in the disease trajectory, or during the
survivorship period, are encouraged.
Further, this FOA seeks to
stimulate research on the impact that interacting symptoms have on
patient experience and quality of life. Interacting symptoms may or may
not be characterized as true symptom clusters. The FOA particularly
encourages the design and testing of interventions addressing symptoms
that have demonstrated interactions or common pathways. For situations
where the knowledge base remains insufficient for intervention design,
mechanistic and methodological studies are encouraged. In this way,
knowledge can be developed and applied to the management of multiple
interacting symptoms or symptom clusters in relation to a variety of
physiological, psychosocial, and demographic factors.
This FOA
requires that the investigator will be concerned with more than one
symptom of cancer or of an immune disorder. Many potential subjects
will likely suffer from comorbid conditions (e.g., older cancer
patients with pre-existing osteoarthritis). The intent of this FOA is
to build a body of research concerned with interacting symptoms
associated with the primary condition; in this case, cancer or an
immune disorder. Subjects with comorbid conditions should be included
when appropriate. In such studies, the presence of comorbidity should
be addressed as a sampling and data analysis concern. The focus of the
research will be on symptoms associated with the primary condition that
is identified (i.e., a type of cancer or an immune disorder). |
| Contact Name: |
Kelli Oster, Grants Management Specialist |
| Contact Address: |
Office of Grants and Contracts Management
National Institute of Nursing Research (NINR)/NIH
6701 Democracy Boulevard, Suite 710 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-4820 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 594-2177 |
| Contact Fax: |
+1 (301) 402-4502 |
| Contact Email: |
osterk@mail.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/pa-files/PA-08-121.html |
| Date Last Revised: |
March 28, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113194 |
| Keywords: |
Cancer or Carcinogenesis
Immune System Disorders
Oncology
|
| Sponsor Reference No: |
PA-08-121 |
| Funding Type: |
Research
|
| COS Unique Id: |
113196 |
| Title: |
Symptom Interactions in Cancer and Immune Disorders (R21) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 16, 2008
October 16, 2008
February 16, 2009
|
| Deadline Note: |
The opening date is May 16, 2008. AIDS-related
applications are due May 7, September 7, and January 7, annually. The
expiration date is May 8, 2011.
Competing renewals are not allowed for this program. |
| Upper Amount: |
$275,000 |
| Amount Note: |
This FOA will utilize the R21 grant mechanism. The
combined budget for direct costs for the two-year project period may
not exceed $275,000. For example, applicants may request $100,000 in
the first year and $175,000 in the second year to meet the needs of the
project. Normally, no more than $200,000 may be requested in a single
year. Facilities and administrative costs requested by consortium
participants are not included in the direct cost limitation.
This program does not require cost sharing. |
| Eligibility: |
Eligible applicants include institutions of higher
education; nonprofits, for-profits, and small businesses; state and
local governments; Indian/Native American tribal governments and
tribally designated organizations; regional organizations; non-domestic
organizations; eligible agencies of the federal government; and
faith-based or community-based organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
This funding opportunity announcement (FOA) issued
by the National Institute of Nursing Research (NINR), National Cancer
Institute (NCI), National Institute on Aging (NIA), National Institutes
of Health (NIH), solicits grant applications from applicant
organizations that propose to
- identify and assess biological or biobehavioral interactions among two or more related and co-occurring symptoms;
- characterize mechanisms and pathways underlying the symptom interactions;
- elucidate the level of interaction necessary for categorization as a symptom cluster; or
-
design and test interventions targeted to interacting or clustered
symptoms that are hypothesized to lead to beneficial patient outcomes.
A
rationale for the choice of symptoms is needed, not just co-occurrence
of two or more symptoms. The symptoms must be associated with a target
disease or syndrome, or the treatment of this disease or syndrome.
Studies at any point in the disease trajectory, or during the
survivorship period, are encouraged.
Further, this FOA seeks to
stimulate research on the impact that interacting symptoms have on
patient experience and quality of life. Interacting symptoms may or may
not be characterized as true symptom clusters. The FOA particularly
encourages the design and testing of interventions addressing symptoms
that have demonstrated interactions or common pathways. For situations
where the knowledge base remains insufficient for intervention design,
mechanistic and methodological studies are encouraged. In this way,
knowledge can be developed and applied to the management of multiple
interacting symptoms or symptom clusters in relation to a variety of
physiological, psychosocial, and demographic factors.
This FOA
requires that the investigator will be concerned with more than one
symptom of cancer or of an immune disorder. Many potential subjects
will likely suffer from comorbid conditions (e.g., older cancer
patients with pre-existing osteoarthritis). The intent of this FOA is
to build a body of research concerned with interacting symptoms
associated with the primary condition; in this case, cancer or an
immune disorder. Subjects with comorbid conditions should be included
when appropriate. In such studies, the presence of comorbidity should
be addressed as a sampling and data analysis concern. The focus of the
research will be on symptoms associated with the primary condition that
is identified (i.e., a type of cancer or an immune disorder). |
| Contact Name: |
Kelli Oster, Grants Management Specialist |
| Contact Address: |
Office of Grants and Contracts Management
National Institute of Nursing Research (NINR)/NIH
6701 Democracy Boulevard, Suite 710 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-4820 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 594-2177 |
| Contact Fax: |
+1 (301) 402-4502 |
| Contact Email: |
osterk@mail.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/pa-files/PA-08-122.html |
| Date Last Revised: |
March 28, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113196 |
| Keywords: |
Cancer or Carcinogenesis
Immune System Disorders
Oncology
|
| Sponsor Reference No: |
PA-08-122 |
| Funding Type: |
Research
|
| COS Unique Id: |
3231 |
| Title: |
Alternatives Research Grant Program |
| Sponsor: |
Alternatives Research and Development Foundation (ARDF)
|
| Sponsor Type: |
Private Foundation |
| Deadline: |
April 30, 2008
|
| Deadline Note: |
Grant proposals should be sent to the ARDF via the
U.S. Postal Service, Federal Express, UPS, or similar carrier,
postmarked by the deadline. |
| Upper Amount: |
$40,000 |
| Amount Note: |
Maximum funding available (total of direct and
indirect costs) is $40,000. Funds will be distributed by August 1,
2008. Funding is for one year. Grants from ARDF may not be used for the
principal investigator's salary or salary supplements, fringe benefits,
or travel. Salary and fringe benefits for technicians, graduate
students, and related personnel are permitted. The foundation is only
able to provide up to 10 percent for indirect costs. Applicants are
encouraged to request an indirect cost waiver from their institutions.
If this is not possible, indirect costs must be justified in the budget
and assurances provided that funds will not support programs contrary
to ARDF's mission to replace and reduce animal-based research methods. |
| Eligibility: |
Grants from ARDF are made only to individuals
affiliated with a nonprofit, tax-exempt, institution, organization, or
foreign equivalent. Preference will be given to proposals from
individuals associated with U.S. institutions or organizations.
Projects
may be submitted without prior approval of the appropriate
institutional review entity. Successful applications must have such
approval, however, before funds can be disbursed. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The mission of ARDF is to fund and promote the
development, validation, and adoption of non-animal methods in
biomedical research, product testing, and education. Preferential
consideration will be given to proposals that utilize human rather than
nonhuman vertebrate tissue. Proposals are judged primarily on the basis
of (1) the extent to which the project will significantly reduce or
replace laboratory animals and (2) scientific merit and feasibility.
Proposals
will not be considered if the project uses intact, nonhuman vertebrate
or invertebrate animals or uses monoclonal antibodies produced by in
vivo methods. Source and production method for all antibodies must be
clearly identified in the proposal. In addition, ARDF strongly
discourages the use of serum or medium supplements obtained from
non-human vertebrates, e.g. FBS, and expects investigators to explain
how such products, if currently used, might be phased out in initial
stages of the project. |
| Contact Address: |
Alternatives Research and Development Foundation
Alternatives Research Grant Program
801 Old York Road, #316 |
| Contact City: |
Jenkintown |
| Contact State: |
Pennsylvania |
| Contact Zip: |
19046 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (215) 887-8076 |
| Contact Fax: |
+1 (215) 887-0771 |
| Contact Email: |
grants08@ardf-online.org |
| URL for more information: |
http://www.ardf-online.org/ |
| Date Last Revised: |
March 24, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=3231 |
| Keywords: |
Animal Welfare
Laboratory Animal Science
|
| Funding Type: |
Research
|
| COS Unique Id: |
43351 |
| Title: |
Census of Marine Life |
| Sponsor: |
Sloan Foundation, Alfred P.
Science and Technology
Direct Support of Research
|
| Sponsor Type: |
Private Foundation |
| Deadline Note: |
Continuous. Grant requests can be made at any time.
A brief letter of inquiry, rather than a fully developed proposal, is
an advisable first step for an applicant. |
| Eligibility: |
The foundation is generally limited to supporting tax-exempt organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Nonprofit
|
| Abstract: |
The goal of this project is to advance a major new
international observational program to be completed by 2010 to assess
and explain the diversity, distribution, and abundance of marine life.
During
1997-1998 the goal of the Alfred P. Sloan Foundation was to understand
the technical and institutional feasibility of a marine census.
Favorable technical and institutional signals led during 1999 to
adopting the ambitious goal of trying to make the census happen. An
international Scientific Steering Committee and Secretariat based at
the Consortium for Oceanographic Research and Education in Washington,
DC, now guide the program. Most grant-making occurs in conjunction with
the National Ocean Partnership Program. The first round of grants
focused on creation of the Ocean Biogeographical Information System
(OBIS), the framework for assimilation of data for the census. In
addition, support has been provided to initiate planning for possible
pilot field projects and to develop information on the history of
marine animal populations.
The Sloan Foundation plans to
continue to support the institutional framework for the census. It will
also consider efforts to address particular, indispensable scientific
needs on which the success of the census will rest. Also, the
foundation seeks opportunities to work with the institutions and media
that can build public interest and with maritime industries and
environmentalists to assure their meaningful participation. |
| Contact Name: |
Jesse H. Ausubel, Program Director |
| Contact Address: |
Alfred P. Sloan Foundation
630 Fifth Avenue, Suite 2550 |
| Contact City: |
New York |
| Contact State: |
New York |
| Contact Zip: |
10111 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (212) 649-1649 |
| Contact Fax: |
+1 (212) 757-5117 |
| Contact Email: |
ausubel@sloan.org |
| URL for more information: |
http://www.sloan.org/programs/scitech_supresearch.shtml |
| Date Last Revised: |
March 26, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=43351 |
| Keywords: |
Ichthyology
Marine Biology
Marine Zoology
|
| Funding Type: |
Research
|
| COS Unique Id: |
57319 |
| Title: |
UNESCO Chairs/UNITWIN Networks (University Twinning and Networking Scheme) Programme |
| Sponsor: |
United Nations (UN)
United Nations Educational, Scientific and Cultural Organization (UNESCO)
|
| Sponsor Type: |
Multinational Organization |
| Deadline: |
April 30, 2008
|
| Deadline Note: |
The deadline for submission of new projects under UNITWIN is April 30 each year. |
| Eligibility: |
Those eligible to apply include universities and
other institutions of higher education and research that are recognized
as bona fide institutions by the competent national authorities in the
respective country and accepted by UNESCO; NGOs working in the field of
higher education and research; other academic associations;
inter-university and other academic networks that wish to establish a
link between their own activities and the UNITWIN Programme; and
national, regional, and international public or private institutions
and agencies that currently have or intend to develop cooperative links
and arrangements with UNESCO in the field of higher education. |
| Citizenship or Residency: |
Less Developed Countries (LDC)
UNESCO
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Nonprofit
Academic Institution
|
| Abstract: |
The UNITWIN/UNESCO Chairs Programme was conceived
as a way to advance research, training, and programme development in
higher education by building university networks and encouraging
inter-university cooperation through transfer of knowledge across
borders. This UNESCO programme serves as a prime means of capacity
building through the exchange of knowledge and sharing in a spirit of
solidarity. Thus it promotes north-south and south-south cooperation as
a strategy to enrich institutions. UNITWIN opens avenues for the higher
education community to join forces with UNESCO to achieve the
objectives of the global agenda. The UNITWIN Programme covers training,
research, and exchange of academics and offers a platform for
information sharing in all major fields within the competence of UNESCO.
The
majority of the projects are interdisciplinary and intersectoral and
involve all programme sectors at UNESCO Headquarters in Paris and its
field offices, institutes, and centres. National commissions play an
important role in helping to facilitate the programme to promote
quality and assess impact. Relevance and effectiveness, at national,
regional, and global levels are among the prime goals of the programme.
So far UNITWIN projects have proven useful in establishing new teaching
programmes, generate new ideas through research and reflection, and
have facilitated enrichment of existing university programmes through
integration of cultural diversity. Because of the flexibility of the
UNITWIN Programme, universities can respond more readily and with
greater autonomy to the demands for new learning.
A Chair can
be established as a new teaching and research unit at a university or
other institution of higher education or research for an initial period
of three years. Such a unit should include the following:
1. A chair holder as its academic head
2.
A number of lecturers and researchers from the host institution and
from other institutions, both in the country concerned and from abroad
(particularly developing countries and those in transition) who are
associated with the activities of the chair
3. A number of students and researchers pursuing postgraduate studies or high-level training and research under the chair
A
group of universities in different countries (north-south, or
south-south) may decide to join forces in addressing an area of need in
the development context and so doing establish a Network. Within this
network, each participating institution may or may not have an
individual chair. However in practice, institutions in the network
progress towards establishing individual chairs. The partnership is
formal and is established through a Memorandum of Understanding (MOU)
for a duration of five years among the participating institutions, that
sets out the purpose of the network, its expected outputs, how it will
function and how it will be sustained. |
| Contact Name: |
Director |
| Contact Address: |
Division of Higher Education
UNESCO
7, Place de Fontenoy |
| Contact City: |
75352 Paris 07SP |
| Contact Country: |
France |
| Contact Fax: |
+33 (1) 4568-5626
+33 (1) 4568-5627 |
| Contact Email: |
unitwin@unesco.org |
| URL for more information: |
http://portal.unesco.org/education/en/ev.php-URL_ID=41557&URL_DO=DO_TOPIC&URL_SECTION=201.html |
| Date Last Revised: |
March 27, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=57319 |
| Keywords: |
Adult and Continuing Education
Agricultural Engineering
AIDS
Archaeology
Arts and Culture
Arts and Humanities
Biodiversity
Bioethics
Biological Sciences
Biotechnology
Broadcast Media
Business
Chemical Sciences
Civil or Human Rights
Climatology
Coastal Zone Management
Communications
Cultural Diversity
Cultural or Population Studies
Disputing and Conflict Resolution
Distance Learning
Early Childhood or Preschool Education
Economics
Ecosystems
Education
Energy Sciences
Engineering
Environmental Sciences
Gender Issues
Genetics
Geoscience
Higher Education
HIV
Informatics
International Affairs
Islands or Island Chains
Journalism
Mass Media
Mathematics
Natural and Physical Sciences, Mathematics and Technology
Natural Sciences
Nutrition or Dietetics
Oceanography
Patents, Copyrights, Trademarks
Peace, Disarmament, or Amnesty
Philosophy
Physics
Political Science
Social Sciences
Sustainable Development
Teacher Education
Vocational or Technical Education
Water Resources Management or Planning
|
| Funding Type: |
Program or Curriculum Development or Provision
|
| COS Unique Id: |
93072 |
| Title: |
NIAID Clinical Trial Implementation (U01) Cooperative Agreement |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline Note: |
Varies. Non-required letters of intent are due 30
days before planned application submission dates. Standard receipt
dates apply, beginning with May 1, 2006, for AIDS applications and June
1, 2006, for all other applications. The standard AIDS-related receipt
dates are May 7, September 7, and January 7. The standard receipt dates
for all other applications are June 5, October 5, and February 5.
This program announcement expires on May 8, 2009. |
| Amount Note: |
This funding opportunity will use the NIH single
project (U01) cooperative agreement award mechanism. NIAID has been
spending about $100 million per year to support new and on-going
investigator-initiated clinical trials. In recent years, approximately
$25 million has been awarded annually to support new and competing
renewal investigator-initiated trials. Depending on NIAID clinical
research priorities, NIAID appropriations, and the budgets for support
of investigator-initiated clinical trials, NIAID estimates that it will
continue to support investigator-initiated clinical trials at current
or higher funding levels. Applicants for clinical trial implementation
cooperative agreements may request up to five years of support for
trial implementation.
Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation. |
| Eligibility: |
Only NIAID R34 grantees are eligible to submit
applications in response to this PAR. R34 awardee institutions will be
domestic or foreign, for-profit or nonprofit organizations and public
or private institutions, such as universities, colleges, hospitals, and
laboratories; units of state and local governments; eligible agencies
of the federal government; and faith-based and community-based
organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The National Institute of Allergy and Infectious
Diseases (NIAID) will support investigator-initiated clinical trials
through a two-part grant process: clinical trial planning (R34) grant,
followed by clinical trial implementation cooperative agreement. This
announcement addresses the clinical trial implementation cooperative
agreement; a companion announcement addresses the R34 grant. |
| Contact Name: |
Martin Gutierrez |
| Contact Address: |
Division of AIDS
National Institute of Allergy and Infectious Diseases, NIH, DHHS
6700B Rockledge Drive, Room 4258 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-7620 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 451-2703 |
| Contact Fax: |
+1 (301) 402-1505 |
| Contact Email: |
mgutierrez@niaid.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/pa-files/PAR-05-113.html |
| Date Last Revised: |
March 26, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=93072 |
| Keywords: |
Clinical Medicine
Clinical Research or Studies
Clinical Trial
|
| Sponsor Reference No: |
PAR-05-113 |
| Funding Type: |
Collaboration or Cooperative Agreement
Research
|
| COS Unique Id: |
98711 |
| Title: |
Research Grants in Food Allergy and Anaphylaxis |
| Sponsor: |
Food Allergy and Anaphylaxis Network (FAAN)
|
| Sponsor Type: |
Other Nonprofit |
| Deadline: |
May 7, 2008
|
| Deadline Note: |
Letters of intent are due on the deadline date. |
| Amount: |
$50,000 |
| Upper Amount: |
$150,000 |
| Amount Note: |
One- to two-year grants are awarded in the range of $50,000 to $150,000 annually. |
| Eligibility: |
This grant program is open to investigators in the
United States and worldwide. Investigators in the United States must
have an M.D. or Ph.D. Investigators outside the United States must have
the equivalent. Competitive applicants have a proven track record of
research experience. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The Food Allergy and Anaphylaxis Network (FAAN) is
accepting letters of intent for its competitive grants program that
focuses on the epidemiology, etiology, treatment, and prevention of
food allergy and anaphylaxis. Although proposals involving basic or
clinical research are accepted, applications that will lead to an
immediate or potential impact on the healthcare of persons with
IgE-mediated food allergy are especially encouraged. FAAN's research
program brings together scientists, patients, industry, government, and
foundations to advance research that will improve the quality of life
for patients and provide a guide in finding a cure for food allergy.
FAAN's integrated approach includes consulting with experts and helping
shape research ideas and programs around the world. |
| Contact Name: |
Cara Schmitt, Research Program Director |
| Contact Address: |
The Food Allergy & Anaphylaxis Network
11781 Lee Jackson Highway
Suite 160 |
| Contact City: |
Fairfax |
| Contact State: |
Virginia |
| Contact Zip: |
22033 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (800) 929-4040
+1 (703) 691-3179 |
| Contact Fax: |
+1 (703) 691-2713 |
| Contact Email: |
research@foodallergy.org |
| URL for more information: |
http://www.foodallergy.org/Research/aboutresearch.html |
| Date Last Revised: |
March 26, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=98711 |
| Keywords: |
Allergy
|
| Funding Type: |
Research
|
|
|
©2008, ProQuest LLC All rights reserved
|
|
